Issue 12, 2022

Correction: Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification

Abstract

Correction for ‘Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification’ by Bailiang Wang et al., RSC Adv., 2015, 5, 3597–3604, DOI: 10.1039/c4ra13499k.

Associated articles

Article information

Article type
Correction
Submitted
25 Feb 2022
Accepted
25 Feb 2022
First published
07 Mar 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 7403-7404

Correction: Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification

B. Wang, Q. Lin, T. Jin, C. Shen, J. Tang, Y. Han and H. Chen, RSC Adv., 2022, 12, 7403 DOI: 10.1039/D2RA90020C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements